Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - United Kingdom

United Kingdom

In the United Kingdom, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to €0.50bn.
It is projected that this market will experience an annual growth rate of 6.65% from 2024 to 2029 (CAGR 2024-2029).
When compared to other countries, the in the United States generates the highest revenue in this market, with €10,380.00m in 2024.
In terms of per capita revenue, each person in the United Kingdom contributes €7.34 to the total revenue in 2024.
The United Kingdom has seen a rise in demand for natural and herbal cold & cough remedies in the OTC Pharmaceuticals market.

Key regions: Australia, Japan, India, Brazil, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Cold & Cough Remedies market in United Kingdom has been experiencing steady growth in recent years.

Customer preferences: Customers in the United Kingdom have shown a strong preference for over-the-counter cold and cough remedies. They often choose these products because they are easily accessible and can be purchased without a prescription. Additionally, customers in the United Kingdom tend to prefer products that provide quick relief from symptoms such as coughing, congestion, and sore throat. They also value products that are convenient to use and have minimal side effects.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in United Kingdom is the increasing demand for natural and herbal remedies. Many customers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional medicines. This trend is driven by a desire for more natural and holistic approaches to healthcare. As a result, there has been a rise in the availability of natural cold and cough remedies in the market.Another trend in the market is the growing popularity of combination products. Customers in the United Kingdom are increasingly seeking products that provide relief for multiple symptoms at once. Combination products that offer relief for cough, congestion, and sore throat in a single dose have gained significant traction in the market. This trend is driven by the convenience and efficiency of using a single product to address multiple symptoms.

Local special circumstances: The United Kingdom has a well-developed healthcare system, which includes a strong pharmaceutical industry. This has contributed to the availability and accessibility of cold and cough remedies in the market. Customers in the United Kingdom have easy access to a wide range of products through various channels, including pharmacies, supermarkets, and online retailers.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in United Kingdom can be attributed to several macroeconomic factors. Firstly, the increasing prevalence of cold and cough-related illnesses in the country has resulted in a higher demand for remedies. This is driven by factors such as changing weather patterns, increased pollution levels, and a growing population.Secondly, the rising disposable income levels in the United Kingdom have also contributed to the growth of the market. As customers have more discretionary income, they are more willing to spend on healthcare products, including cold and cough remedies. This has led to an increase in the overall market size.Lastly, the aging population in the United Kingdom is another factor that is driving the growth of the Cold & Cough Remedies market. Older individuals are more susceptible to cold and cough-related illnesses and are therefore more likely to purchase remedies to alleviate their symptoms. The aging population in the United Kingdom is expected to continue growing, which will further fuel the demand for cold and cough remedies in the future.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.